Product
Sirolimus(0.7mg/m2)
1 clinical trial
2 indications
Indication
HemangiomaIndication
Kaposiform HemangioendotheliomaClinical trial
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma:A Prospective, Randomized Open TrialStatus: Completed, Estimated PCD: 2022-12-10